Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease

Symposium
Chairs: R. Huber (Munich, Germany), E. Ruffini (Torino (TO), Italy)
Aims: to enhance understanding of differential treatment algorithms for definitive radiochemotherapy or resection in combination with systemic therapy (and radiotherapy) in patients with locally advanced non-small cell lung cancer (NSCLC); to discuss the new options of targeted therapy and immunotherapy in this potentially curative setting.
Diagnostic work-up in stage III NSCLC including assessment of fitness for radical therapy
J. van den Aardweg (Heemstede, Netherlands)
WebcastSlide presentation
WebcastSlide presentation
New standards and clinical trials of systemic therapies for stage III NSCLC: is there a role for targeted therapies or immunotherapies?
R. Wiewrodt (Münster, Germany)
No content made available
No content made available
Modern radiotherapy as a curative treatment modality for stage III NSCLC
E. Troost (Dresden, Germany)
WebcastSlide presentation
WebcastSlide presentation
Prerequisites, potential and limits of thoracic surgery with curative intent for stage III NSCLC
D. Waller (London, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation